Market Overview
Nanjing Redsun (000525.SZ) concluded the latest trading session with no change, holding steady at CNY 4.05 as of 10:29 AM Central Europe on Monday, 26 November 2026. The stock remains in a tightly contested range, with a 1.3 billion‑share supply and a market capitalisation of CNY 5.6 billion. In the past 24 hours, approximately CNY 89.4 million of shares were traded, reflecting a modest volume relative to the company’s outstanding float.
Since the end of the previous month, Nanjing Redsun has fallen ‑4.47 %, a decline that aligns with broader sectoral pressures. The 200‑day simple moving average sits at CNY 4.46, underscoring the stock’s current proximity to a key resistance level. The 52‑week high of CNY 7.41 (recorded on 13 March 2026) and the 52‑week low of CNY 3.80 (on 29 June 2026) illustrate a moderate but persistent volatility corridor.
Comparative Peer Activity
| Stock | Ticker | 24‑h Performance | Current Price | Market Cap (CNY/HKD) |
|---|---|---|---|---|
| Pateo Connect S‑h | 2889.HK | +2.98 % | HKD 47.3 | HKD 7.8 bn |
| KPC | 600422.SS | 0 % | CNY 8.95 | CNY 6.7 bn |
| Xining Special Steel | 600117.SS | 0 % | CNY 2.05 | CNY 6.6 bn |
| Fawer Automotive Parts | 000030.SZ | 0 % | CNY 3.97 | CNY 6.7 bn |
| Guangxi Beitou | 600936.SS | 0 % | CNY 3.90 | CNY 6.7 bn |
While most peers remained flat, Pateo Connect S‑h’s gain hints at a possible short‑term rotation into higher‑growth names within the Shenzhen‑HK nexus.
Strategic Context
Nanjing Redsun’s core businesses—agricultural pesticides, coatings, and fine chemicals—position it within a sector that has historically rebounded from cyclical dips. The company’s 1993 IPO and long‑standing presence on the Shenzhen Stock Exchange lend it institutional credibility. Recent macro‑economic headwinds, however, have pressured commodity prices and input costs, nudging the company’s earnings profile tighter.
Forward‑Looking Outlook
- Price Target: Analysts project a realistic 12‑month target of CNY 4.70–4.80, contingent on stabilising raw material costs and incremental sales in emerging agro‑chemical markets.
- Catalysts: Upcoming regulatory approvals in Southeast Asia and potential expansion into bio‑based formulations could unlock new revenue streams.
- Risks: Persisting commodity volatility, potential trade restrictions, and the broader global shift towards sustainable pesticides could temper growth.
Investors should monitor the company’s quarterly earnings releases for indications of cost‑control effectiveness and any shift in product mix. Given its solid market cap and disciplined trading volume, Nanjing Redsun remains a candidate for long‑term value creation amid a slowly stabilising industry landscape.